Life Science Automation and Robotics Market Size, Share and Trends 2025 to 2034
Life Science Automation and Robotics Market (By Technology Type: Laboratory Robotics, AI-Driven Autonomous System Robots, Automated Liquid Handling Systems, Automated Storage & Retrieval Systems; By Workflow/Application: Drug Discovery & High-Throughput Screening, Genomics, Proteomics & Cell Biology Automation, Sample Preparation & Handling; By Component: Robotic Systems, Automated Instruments, Integration & Custom Automation Services; By End-User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Medical Device Manufacturers; By Process Area: R&D Laboratories, Clinical & Diagnostic Labs, Quality, Supply Chain & Warehouse Automation; By Distribution Channel: Direct OEM Sales, Automation Integrators, Online Industrial Platforms) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Get a Sample
Table Of Content
What is the Life Science Automation and Robotics Market Size?
The global life science automation and robotics market streamlines research workflows with intelligent automation and AI-driven robotics.The market is driven by rising demand for high-throughput research, precision workflows, and automated systems in drug discovery, diagnostics, and bioprocessing.
Market Highlights
- By region, North America accounted for the largest share of the life science automation and robotics market in 2024.
- By region, the Asia Pacific is anticipated to witness the fastest growth during the forecasted years.
- By technology type, the laboratory robotics segment held the highest share in 2024.
- By technology type, the AI-driven autonomous systems segment is anticipated to show considerable growth in the market over the forecast period.
- By workflow/application, the drug discovery & high-throughput screening (HTS) segment held a significant share in the life science automation and robotics market during 2024.
- By workflow/application, the bioprocessing & biomanufacturing automation segment is anticipated to show considerable growth in the market over the forecast period.
- By component, the robotic systems segment held a significant share in 2024.
- By component, the software & digital control platforms segment is anticipated to show considerable growth in the market over the forecast period.
- By end user, the pharmaceutical companies segment held a significant share in 2024.
- By end user, the CDMS/CMOS segment is anticipated to show considerable growth in the market over the forecast period.
- By process area, the R&D laboratories segment held the largest share in the life science automation and robotics market 2024.
- By process area, the manufacturing & packaging automation segment is anticipated to show considerable growth in the market over the forecast period.
- By distribution channel, the direct OEM sales segment held a significant share in 2024.
- By distribution channel, the automation integrators segment is anticipated to show considerable growth in the market over the forecast period.
Redefining Remote Care: How AI Is Transforming the Telemedicine Value Chain
The life science automation and robotics market includes automated hardware systems, robotics platforms, software -based lab orchestration systems, and smart instrumentation used in pharmaceutical , biotechnology , medical device manufacturing, academic research centers, CROs, and CDMOs. Applications of end-to-end scientific workflows in drug discovery , high-throughput screening, omics-based research, sample preparation, bioprocessing, cell line development, diagnostics, fill-format, and packaging are supported by solutions. The markets development is indicative of industry-wide trends toward digital, data-intensive research and development (R&D), in which integrated robotics systems are paired with cloud-connected analytics platforms to streamline laboratory workflows.
The drivers of this growth are increasing R&D complexity, expanding biologic pipelines, and the growing need for scalable systems that support multimodal workflows in therapeutics, such as mRNA, cell therapies, and antibody platforms. One of the driving forces of the AIs that allow autonomous optimization of assays, predictive scheduling of experiments, intelligent motion control, QC automation, and real-time detection of anomalies in biomanufacturing lines is AI. As discovery becomes more focused on precise automation of commercial manufacturing steps, the market is still transitioning towards individual robots being linked and towards AI-enhanced laboratory environments.
Key AI Integrations in the Life Science Automation and Robotics Market
The new generation of life sciences is being conducted through AI, which enhances accuracy, accelerates the experimental process, and improves regulatory traceability across drug discovery and biomanufacturing. Applications of machine learning models, which are becoming increasingly popular, include autonomous optimisation of assays, adaptive experimental design, image-based cell analysis, and predictive modelling of molecular interactions. Motion control, AI-based robotic path planning, and automated lab systems make sample handling more efficient, less prone to contamination, and enable real-time calibration of liquid handling systems. Bio-processing platforms utilise AI for anomaly detection, predictive maintenance , quality monitoring, and closed-loop control systems that regulate parameters based on live sensor data.
Life Science Automation and Robotics Market Outlook
[[market_outlook]]
Market Scope
| Report Coverage | Details |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Technology Type, Workflow/Application, Component, End-User, Process Area, Distribution Channel, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Life Science Automation and Robotics Market Segment Insights
[[segment_insights]]
Life Science Automation and Robotics MarketRegion Insights
[[regional_insights]]
Life Science Automation and Robotics Market Companies
[[market_company]]
Recent Developments
- In September 2025, Merck and Siemens renewed a Memorandum of Understanding to develop AI and data-based drug discovery and development. The alliance aims to merge software, systems, consumables, and automotive tools to coordinate the processes of discovery, development, and manufacturing smoothly.(Source: https://www.ddw-online.com )
- In May 2025, GE Healthcare was also approved to produce its new MRI system powered by industrial automation technologies. The systems faster imaging and increased patient comfort represent a significant breakthrough in diagnostic imaging.(Source: https://www.massdevice.com )
- In October 2024, Siemens Healthineers released Atellica Integrated Automation for the Atellica CI Analyst, integrating 25 manual tasks and reducing manual workflow actions by 75 percent. The system improves operational efficiency by automating routine sample handling and reducing turnaround times, enabling the lab to overcome staffing shortages in the global market.(Source: https://respiratory-therapy.com )
Life Science Automation and Robotics MarketSegments Covered in the Report
[[segment_covered]]
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting